Company Registration No. 05316858 (England and Wales)
CHEMOVATION LIMITED
Annual Report and Statement of Accounts
For the Period from 01 January 2025 to 31 December 2025

CHEMOVATION LIMITED

Annual report and statement of accounts for the period ending 31/12/2025

CHEMOVATION LIMITED

Financial statement for the period ended 31/12/2025

Company Information

1 Statutory Information
Company Number 05316858
Registered Office 25 LEAMSIDE HOUSE LUCAS COURT
LEAMINGTON SPA
ENGLAND
CV32 5JL
2 Directors
Directors who held office during the period were:
HUGL, Linda, Dr   
MATTHEWS, Ian Timothy William, Dr   
3 Principal Activity
The Company's principle activity during the period was providing drug discovery services to the pharmaceutical industry.
4 Employees
Average number of employees, including directors, during the year was as follows:
2025 0
2024 0

CHEMOVATION LIMITED

Financial statement for the period ended 31/12/2025

Statement of Financial Position

2025 2024
£ £
Fixed Assets - -
Current Assets 146 89
Creditors: amounts falling due within one year - -
Net Current Assets 146 89
Total assets less current liabilities 146 89
Creditors: amounts falling due after one year (167,276) (165,676)
Net Assets (167,130) (165,587)
Capital and reserves (167,130) (165,587)
For the period ending 31/12/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 25 September 2026
Linda Hugl
Company Registration No. 05316858